2020
Can Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents?
Merriam A, Paidas M. Can Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents? 2020, 223-230. DOI: 10.1201/9780429450303-24.ChaptersRecurrent pregnancy lossPregnancy outcomesAntiplatelet agentsPregnancy lossAntithrombotic agentsMultiple adverse pregnancy outcomesSmall case-control studyAntiplatelet agent aspirinAdverse pregnancy outcomesSuccessful pregnancy outcomeCase-control studyMultiple prospective studiesHistory of thrombophiliaClass of drugsEffects of anticoagulantsAspirin treatmentProspective studyAnticoagulant agentsLive birthsThrombophiliaBlood clotsWomenAspirinOutcomesAgents
2015
Maternal disorders affecting labor and delivery
Merriam A, Sciscione A. Maternal disorders affecting labor and delivery. 2015, 283-347. DOI: 10.1002/9781118327241.ch13.Peer-Reviewed Original ResearchMedical conditionsHigh-risk medical conditionsManagement of anticoagulationStructural heart lesionsProcess of laborChronic hypertensionHypertensive disordersMaternal disordersAdverse outcomesHeart lesionsNeurologic conditionsHeart diseaseHematologic disordersFetal conditionInfectious diseasesDisordersFetusesMothersDiseaseWomenManagement strategiesDeliveryAnticoagulationHypertensionDiabetes
2014
443: A prospective evaluation of the effectiveness of vaginal fetal fibronectin to predict preterm birth in women with symptoms of preterm labor in the outpatient setting
Merriam A, Sciscione A, Daniel L. 443: A prospective evaluation of the effectiveness of vaginal fetal fibronectin to predict preterm birth in women with symptoms of preterm labor in the outpatient setting. American Journal Of Obstetrics And Gynecology 2014, 210: s224. DOI: 10.1016/j.ajog.2013.10.476.Peer-Reviewed Original Research